Antibodies: Complement Activation

The complement system can be activated by antigen-associated antibody. In the classical pathway of complement activation, C1q, C4b, and C3b are all able to bind to the Fc portion of IgG or IgM. Find the latest research on antibodies and complement activation here.

January 17, 2022

Identification of novel classes for patients with lupus nephritis using two-step cluster model.

Wiener klinische Wochenschrift
Ting HuangHui Luo
January 17, 2022

Classical complement pathway factor alterations in narcolepsy.

Acta Neuropsychiatrica
Hande YüceerCem İsmail Küçükali
January 17, 2022

Cardiac troponin T and autoimmunity in skeletal muscle aging.

GeroScience
Tan ZhangStephen Kritchevsky
January 17, 2022

[Pathogenesis of ANCA-associated vasculitides in 2021: An update].

La Revue de médecine interne
A NéelM Hamidou
January 15, 2022

Antineonatal Fc Receptor Antibody Treatment Ameliorates MOG-IgG-Associated Experimental Autoimmune Encephalomyelitis.

Neurology. Neuroimmunology and Neuroinflammation
Jana RemlingerAnke Salmen
January 14, 2022
Open Access

Toxoplasmosis impact on prematurity and low birth weight.

PloS One
Karel HurtJakub Rakovic
January 13, 2022
Preprint
Open Access

A unique dexamethasone-dependent gene expression profile in the lungs of COVID-19 patients

MedRxiv : the Preprint Server for Health Sciences
U. FahnoeR. R. Plovsing
January 14, 2022
Case Report

[Small B-cell neoplasm responding to ibrutinib after 17 years of cold agglutinin disease symptom].

[Rinshō ketsueki] The Japanese journal of clinical hematology
Suguru MorimotoAkifumi Takaori-Kondo
January 12, 2022
Preprint
Open Access

NOVEL PLASMA GLYCOPROTEIN BIOMARKERS PREDICT PROGRESSION-FREE SURVIVAL IN SURGICALLY RESECTED CLEAR CELL RENAL CELL CARCINOMA

MedRxiv : the Preprint Server for Health Sciences
D. SerieDavid D Thiel
January 11, 2022

Eculizumab Use in a Temporarily Dialysis-Dependent Patient With Shiga Toxin-Producing Escherichia Coli Hemolytic Uremic Syndrome With Neurological Complications.

The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG
Bo WeberSandy Hammer
January 11, 2022

C5aR2 deficiency ameliorates inflammation in murine epidermolysis bullosa acquisita by regulating FcγRIIb expression on neutrophils.

The Journal of Investigative Dermatology
Daniel L SeilerChristian M Karsten
January 9, 2022
Review

Sculpting therapeutic monoclonal antibody N-glycans using endoglycosidases.

Current Opinion in Structural Biology
Beatriz TrastoyMarcelo E Guerin

Sign up to follow this feed and discover related papers.

Related Feeds

Antibodies: Agglutination

Antibody-mediated agglutination is the clumping of cells in the presence of antibody, which binds multiple cells together. This enhances the clearance of pathogens. Find the latest research on antibody-mediated agglutination here.

Antibody Development

Development of antibodies require integration of knowledge with respect to target antigen properties, antibody design criteria such as affinity, isotype selection, Fc domain engineering, and antibody cross-reactivity across species from the early stages of antibody development. Here is the latest research.


Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.

Antibody synthesis

Antibodies have various functions including neutralization of pathogens, tumor targeting, as well as its utility in biomedical research. Here is the latest research on antibody synthesis.

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.

Antibody-Dependent Enhancement

Antibody-dependent enhancement of viral infection is the entry of virus into host cells mediated by antiviral antibodies interacting with Fc or complement receptors. This has been most extensively observed with the dengue virus. Find the latest research on antibody-dependent enhancement here.

Antigenic Modulation

Antigenic modulation occurs when an antibody cross-links antigens on a cell surface, causing the antigens to become internalized. This can lead to therapeutic failure of monoclonal antibodies as the expression of the antigen becomes decreased on target cells. Find the latest research on antigenic modulation here.

B cell Activation

B cell activation is initiated by the ligation of the B cell receptor with antigen and ultimately results in the production of protective antibodies against potentially pathogenic invaders. Here is the latest research.

B cell Differentiation

Depending on the signal received through the B cell receptor and other receptors, B cells differentiate into follicular or marginal zone B cells. Here is the latest research pertaining to this differentiation process.

B cell Tolerance

B cell tolerance is maintained through mechanisms that can reversibly or irreversibly silence autoreactive B lymphocytes. Here is the latest research.

© 2022 Meta ULC. All rights reserved
/feed-previews/antibodies-complement-activation/f4145618-ae60-4266-aad5-98861d411064